Mark Dean-Netscher has been appointed chief operating officer of Penn Pharma, effective May 16th. Mr. Dean-Netscher will be responsible for overseeing operation of the company’s specials and global contract manufacturing and development services, including analytical services, formulation, clinical trial supplies, logistics and commercial manufacturing and packaging. Mr. Dean-Netscher has more than 20 years of experience in the pharmaceutical manufacturing industry. He has held senior positio...